A study published in the Annals of Neurology found that younger and middle-aged patients are disproportionately affected by neurologic manifestations of postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection (Neuro-PASC). The study included 200 posthospitalization Neuro-PASC patients and 1,100 nonhospitalized Neuro-PASC patients assessed at a Neuro-COVID-19 clinic. Older patients showed higher prevalence of comorbidities and abnormal neurologic findings, while younger patients had a lower prevalence and symptom burden. This disparity in symptoms could lead to increased health care burden, mental health issues, and economic impact, as younger adults are more affected by long-term neurological issues related to COVID-19.
Source link
Younger patients more affected by neurologic manifestations of long COVID
